Impact of the COVID-19 pandemic on breast cancer screening volumes and patient screening behaviors
- PMID: 34032985
- PMCID: PMC8145189
- DOI: 10.1007/s10549-021-06252-1
Impact of the COVID-19 pandemic on breast cancer screening volumes and patient screening behaviors
Abstract
Purpose: In order to facilitate targeted outreach, we sought to identify patient populations with a lower likelihood of returning for breast cancer screening after COVID-19-related imaging center closures.
Methods: Weekly total screening mammograms performed throughout 2019 (baseline year) and 2020 (COVID-19-impacted year) were compared. Demographic and clinical characteristics, including age, race, ethnicity, breast density, breast cancer history, insurance status, imaging facility type used, and need for interpreter, were compared between patients imaged from March 16 to October 31 in 2019 (baseline cohort) and 2020 (COVID-19-impacted cohort). Census data and an online map service were used to impute socioeconomic variables and calculate travel times for each patient. Logistic regression was used to identify patient characteristics associated with a lower likelihood of returning for screening after COVID-19-related closures.
Results: The year-over-year cumulative difference in screening mammogram volumes peaked in week 21, with 2962 fewer exams in the COVID-19-impacted year. By week 47, this deficit had reduced by 49.4% to 1498. A lower likelihood of returning for screening after COVID-19-related closures was independently associated with younger age (odds ratio (OR) 0.78, p < 0.001), residence in a higher poverty area (OR 0.991, p = 0.014), lack of health insurance (OR 0.65, p = 0.007), need for an interpreter (OR 0.68, p = 0.029), longer travel time (OR 0.998, p < 0.001), and utilization of mobile mammography services (OR 0.27, p < 0.001).
Conclusion: Several patient factors are associated with a lower likelihood of returning for screening mammography after COVID-19-related closures. Knowledge of these factors can guide targeted outreach to vulnerable patients to facilitate breast cancer screening.
Keywords: Breast cancer; COVID-19 pandemic; Patient travel time; Screening mammography.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
None of the authors has any conflict of interest or competing interests related to this study.
Figures


References
-
- Malhotra A, Wu X, Fleishon HB, Duszak R, Jr, Silva E, 3rd, McGinty GB, Bender C, Williams B, Pashley N, Stengel CJB, Naidich JJ, Hughes D, Sanelli PC. Initial impact of COVID-19 on radiology practices: An ACR/RBMA survey. J Am Coll Radiol. 2020;17(11):1525–1531. doi: 10.1016/j.jacr.2020.07.028. - DOI - PMC - PubMed
-
- Norbash AM, Moore AV, Jr, Recht MP, Brink JA, Hess CP, Won JJ, Jain S, Sun X, Brown M, Enzmann D. Early-stage radiology volume effects and considerations with the coronavirus disease 2019 (COVID-19) Pandemic: adaptations, risks, and lessons learned. J Am Coll Radiol. 2020;17(9):1086–1095. doi: 10.1016/j.jacr.2020.07.001. - DOI - PMC - PubMed
-
- ASBrS and ACR Joint Statement on Breast Screening Exams During the COVID-19 Pandemic (2020). https://www.breastsurgeons.org/news/?id=45. Accessed 10 Feb 2021
-
- Society of Breast Imaging Statement on Breast Imaging during the COVID-19 Pandemic (2020). https://www.sbi-online.org/Portals/0/Position%20Statements/2020/society-.... Accessed 10 Feb 2021
-
- ACR Guidelines for Resumption of Breast Cancer Screening (2020) https://www.acr.org/-/media/ACR/Files/Breast-Imaging-Resources/Care-Tool.... Accessed 10 Feb 2021
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical